• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染中特定变异体和疫苗接种的可变剪接图谱

Variant- and vaccination-specific alternative splicing profiles in SARS-CoV-2 infections.

作者信息

Lee Sung-Gwon, Furth Priscilla A, Hennighausen Lothar, Lee Hye Kyung

机构信息

Section of Genetics and Physiology, Laboratory of Molecular and Cellular Biology, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.

出版信息

iScience. 2024 Feb 8;27(3):109177. doi: 10.1016/j.isci.2024.109177. eCollection 2024 Mar 15.

DOI:10.1016/j.isci.2024.109177
PMID:38414855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10897911/
Abstract

The COVID-19 pandemic, driven by the SARS-CoV-2 virus and its variants, highlights the important role of understanding host-viral molecular interactions influencing infection outcomes. Alternative splicing post-infection can impact both host responses and viral replication. We analyzed RNA splicing patterns in immune cells across various SARS-CoV-2 variants, considering immunization status. Using a dataset of 190 RNA-seq samples from our prior studies, we observed a substantial deactivation of alternative splicing and RNA splicing-related genes in COVID-19 patients. The alterations varied significantly depending on the infecting variant and immunization history. Notably, Alpha or Beta-infected patients differed from controls, while Omicron-infected patients displayed a splicing profile closer to controls. Particularly, vaccinated Omicron-infected individuals showed a distinct dynamic in alternative splicing patterns not widely shared among other groups. Our findings underscore the intricate interplay between SARS-CoV-2 variants, vaccination-induced immunity, and alternative splicing, emphasizing the need for further investigations to deepen understanding and guide therapeutic development.

摘要

由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒及其变体引发的新冠疫情,凸显了理解影响感染结果的宿主-病毒分子相互作用的重要作用。感染后的可变剪接可影响宿主反应和病毒复制。我们考虑了免疫状态,分析了不同SARS-CoV-2变体感染的免疫细胞中的RNA剪接模式。利用我们先前研究中的190个RNA测序样本数据集,我们观察到新冠患者中可变剪接和RNA剪接相关基因大量失活。这些改变因感染变体和免疫史的不同而有显著差异。值得注意的是,感染阿尔法或贝塔变体的患者与对照组不同,而感染奥密克戎变体的患者的剪接谱更接近对照组。特别是,接种疫苗的奥密克戎感染个体在可变剪接模式上表现出独特的动态变化,这在其他组中并不常见。我们的研究结果强调了SARS-CoV-2变体、疫苗诱导的免疫力和可变剪接之间的复杂相互作用,强调需要进一步研究以加深理解并指导治疗开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c716/10897911/b43360b8206d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c716/10897911/284d4f095984/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c716/10897911/3f0c386d3304/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c716/10897911/0b790f3ef5ca/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c716/10897911/5a3dd3777959/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c716/10897911/b43360b8206d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c716/10897911/284d4f095984/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c716/10897911/3f0c386d3304/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c716/10897911/0b790f3ef5ca/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c716/10897911/5a3dd3777959/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c716/10897911/b43360b8206d/gr4.jpg

相似文献

1
Variant- and vaccination-specific alternative splicing profiles in SARS-CoV-2 infections.新冠病毒感染中特定变异体和疫苗接种的可变剪接图谱
iScience. 2024 Feb 8;27(3):109177. doi: 10.1016/j.isci.2024.109177. eCollection 2024 Mar 15.
2
Variant- and Vaccination-Specific Alternative Splicing Profiles in SARS-CoV-2 Infections.SARS-CoV-2感染中变体和疫苗特异性的可变剪接图谱
bioRxiv. 2023 Nov 27:2023.11.24.568603. doi: 10.1101/2023.11.24.568603.
3
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections.初次感染 SARS-CoV-2 奥密克戎 BA.1 和 BA.2 株后中和抗体的不同反应特征
Front Immunol. 2022 Jul 19;13:946318. doi: 10.3389/fimmu.2022.946318. eCollection 2022.
4
SARS-CoV-2 Evolution and Patient Immunological History Shape the Breadth and Potency of Antibody-Mediated Immunity.SARS-CoV-2 进化和患者免疫史塑造了抗体介导免疫的广度和效力。
J Infect Dis. 2022 Dec 28;227(1):40-49. doi: 10.1093/infdis/jiac332.
5
SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant.SARS-CoV-2 的 Alpha、Beta、Delta 和奥密克戎变异株与早期大流行变异株相比,宿主细胞干扰素反应较慢。
Front Immunol. 2022 Sep 30;13:1016108. doi: 10.3389/fimmu.2022.1016108. eCollection 2022.
6
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.mRNA 疫苗诱导的 T 细胞对 SARS-CoV-2 关切变异株的反应完全相同,但根据先前的感染状态,其持久性和归巢特性存在差异。
Elife. 2021 Oct 12;10:e72619. doi: 10.7554/eLife.72619.
7
Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.感染野生型、德尔塔和奥密克戎 SARS-CoV-2 后及接种疫苗前的新冠后状况:两项基于人群队列的合并分析。
PLoS One. 2023 Feb 22;18(2):e0281429. doi: 10.1371/journal.pone.0281429. eCollection 2023.
8
Diagnostic Sensitivity of Saliva and Other Respiratory Tract Samples of SARS-CoV-2 Variants in Patients with COVID-19.新冠病毒感染患者中唾液及其他呼吸道样本对SARS-CoV-2变异株的诊断敏感性
Microbiol Spectr. 2023 Mar 28;11(2):e0307622. doi: 10.1128/spectrum.03076-22.
9
Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)毒株,即武汉毒株、德尔塔变种和奥密克戎变种的分析,确定了不同的免疫特征。
Microbiol Spectr. 2023 Sep 7;11(5):e0125623. doi: 10.1128/spectrum.01256-23.
10
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.COVID-19 患者在突破感染 SARS-CoV-2 变异株 Delta、Omicron-BA.1 和 Omicron-BA.5 期间的免疫反应。
Front Immunol. 2023 Jul 13;14:1150667. doi: 10.3389/fimmu.2023.1150667. eCollection 2023.

本文引用的文献

1
Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection.多组学生物血图谱揭示了对 SARS-CoV-2 奥密克戎突破性感染的免疫和血小板反应的独特特征。
Immunity. 2023 Jun 13;56(6):1410-1428.e8. doi: 10.1016/j.immuni.2023.05.007. Epub 2023 May 16.
2
Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network.在 SARS-CoV-2 奥密克戎变异株广泛传播期间,既往 SARS-CoV-2 感染和 COVID-19 疫苗对门诊疾病的有效性,美国流感疫苗效果监测网络。
Influenza Other Respir Viruses. 2023 May;17(5):e13143. doi: 10.1111/irv.13143.
3
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
既往 SARS-CoV-2 感染对再感染的保护作用:系统评价和荟萃分析。
Lancet. 2023 Mar 11;401(10379):833-842. doi: 10.1016/S0140-6736(22)02465-5. Epub 2023 Feb 16.
4
Genome-wide characterization of alternative splicing in blood cells of COVID-19 and respiratory infections of relevance.COVID-19 患者血细胞中可变剪接的全基因组特征及相关呼吸道感染
Virol Sin. 2023 Apr;38(2):309-312. doi: 10.1016/j.virs.2023.01.007. Epub 2023 Jan 20.
5
Analysis of immune responses in patients with CLL after heterologous COVID-19 vaccination.CLL 患者异源 COVID-19 疫苗接种后的免疫应答分析。
Blood Adv. 2023 May 23;7(10):2214-2227. doi: 10.1182/bloodadvances.2022008445.
6
The landscape of differential splicing and transcript alternations in severe COVID-19 infection.严重 COVID-19 感染中差异剪接和转录变异的景观。
FEBS J. 2023 Jun;290(12):3128-3144. doi: 10.1111/febs.16723. Epub 2023 Jan 26.
7
Computer-aided drug design combined network pharmacology to explore anti-SARS-CoV-2 or anti-inflammatory targets and mechanisms of Qingfei Paidu Decoction for COVID-19.计算机辅助药物设计结合网络药理学探索清肺排毒汤抗 SARS-CoV-2 或抗炎的靶点和作用机制治疗 COVID-19。
Front Immunol. 2022 Dec 23;13:1015271. doi: 10.3389/fimmu.2022.1015271. eCollection 2022.
8
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19.COVID-19 中的固有免疫、细胞因子风暴和炎症细胞死亡。
J Transl Med. 2022 Nov 22;20(1):542. doi: 10.1186/s12967-022-03767-z.
9
The role of KRAS splice variants in cancer biology.KRAS剪接变体在癌症生物学中的作用。
Front Cell Dev Biol. 2022 Nov 1;10:1033348. doi: 10.3389/fcell.2022.1033348. eCollection 2022.
10
Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients.新冠病毒奥密克戎BA.2对未感染过新冠病毒的初诊门诊患者引发的交叉变异免疫反应有限。
iScience. 2022 Nov 18;25(11):105369. doi: 10.1016/j.isci.2022.105369. Epub 2022 Oct 14.